MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis
Eric F. Morand(Novartis (Switzerland)), Jürgen Bernhagen(LMU Klinikum), Michelle Leech(Monash Institute of Medical Research)
Cited by 348
Related Papers
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
|Annals of the Rheumatic Diseases|2015|728
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726